Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene test may unlock hypnosis power for pain relief

NCT ID NCT04624880

First seen Apr 28, 2026 · Last updated Jun 15, 2026 · Updated 10 times

Summary

This study looked at whether a genetic marker called COMT can predict how well a person responds to hypnosis for pain after surgery. Researchers tested a new, faster method to read this gene from saliva or blood samples. The goal is to one day use a simple genetic test to personalize pain management and reduce the need for opioids.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Stanford University/Stanford Healthcare

    Palo Alto, California, 94305, United States

Conditions

The condition(s) this trial relates to.

agnosia inherited disease susceptibility Pain Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.